TABLE I. Intracellular distribution of 35S-proteoglycans in corneal fibroblasts.
Corneal fibroblasts were plated at 15,000 cells/cm2 on fibronectin coated plates in serum free medium [Hsia et al., 2003; Richardson et al., 2001] and allowed to incubate for 16h at 37°C. 35SO4 (100 μCi/mL) was added and the cells allowed to incubate for an additional 24 h at 37°C. The 35SO4-labeled cells were suspended with trypsin and ruptured by hypotonic shock and with NP-40. Cell extracts were separated into cytoplasmic and nuclear fractions as described in Experimental Procedures. Samples were subjected to cationic nylon filtration to separate 35S-proteoglycan from unincorporated 35SO4. Duplicate filters were subjected to nitrous acid treatment [Rapraeger and Yeaman, 1989]. 35S-heparan sulfate was calculated by subtracting the nitrous acid resistant 35S-proteogylcan (non-HSPG) from the total PG. Intracellular PG represented ~40% of the total cell-associated PG in these cells, and isolation and quantitation of cell-associated PG generated ~1.5 μg PG/106 cells (based on total GAG using the DMB assay [Farndale et al., 1986]). Hence, estimates of cytoplasmic and nuclear PG levels (μg/106 cells) were calculated as: 1.5*0.4*(relative amount in each fraction).
Fraction | Total PG/106 cells | Non-HSPG/106 cells | HSPG/106 cells | |||
---|---|---|---|---|---|---|
CPM | μg | CPM | μg | CPM | μg | |
Cytoplasmic | 87,318 ± 1,323 | 0.517 | 26,800 ± 2,723 | 0.159 | 60,518 | 0.358 |
Nuclear | 14,044 ± 1,025 | 0.083 | 4,185 ± 68 | 0.025 | 9,859 | 0.058 |